Home | Time for UK plasma to shine
In this issue
Contents
Datwyler
Labcorp
UPS Healthcare Company Insight
UPS Healthcare
Baxter
SHL Medical
Briefing
Industry news
The pharma industry briefing
Covid-19 executive briefing by GlobalData
Mimotopes Company Insight
Mimotopes
PerkinElmer
Comment
A new day for Alzheimer’s disease treatment
Covid-19 vaccine inequity: the debate over patent waivers intensifies
Covid-19 vaccines show efficacy in adolescents
International pharmacovigilance for biotechs: forming a strategy
Nipro
HOF Sonderanlagenbau
Myonex
In Depth
Malaria vaccines through the ages
Are competition authorities tightening the rules on pharma M&A?
The fishy business of shark squalene
Without a trace: can pharma reduce scarring?
Blood plasma production: OK for the UK?
When the drugs don’t work: can pharma keep up with mental health?
The Solubility Company - Company Insight
The Solubility company
Owen Mumford Company Insight
Owen Mumford
In Data
Deals analysis
The pharma industry key list
Global markets and indices
Macro-economic indicators
Macro-economic indicators (page 2)
Events
Next issue
06/18/2021 00:00:00
Go to article:
Home | Time for UK plasma to shine
Go to article:
In this issue
Go to article:
Contents
Go to article:
Datwyler
Go to article:
Labcorp
Go to article:
UPS Healthcare Company Insight
Go to article:
UPS Healthcare
Go to article:
Baxter
Go to article:
SHL Medical
Go to article:
Briefing
Go to article:
Industry news
Go to article:
The pharma industry briefing
Go to article:
Covid-19 executive briefing by GlobalData
Go to article:
Mimotopes Company Insight
Go to article:
Mimotopes
Go to article:
PerkinElmer
Go to article:
Comment
Go to article:
A new day for Alzheimer’s disease treatment
Go to article:
Covid-19 vaccine inequity: the debate over patent waivers intensifies
Go to article:
Covid-19 vaccines show efficacy in adolescents
Go to article:
International pharmacovigilance for biotechs: forming a strategy
Go to article:
Nipro
Go to article:
HOF Sonderanlagenbau
Go to article:
Myonex
Go to article:
In Depth
Go to article:
Malaria vaccines through the ages
Go to article:
Are competition authorities tightening the rules on pharma M&A?
Go to article:
The fishy business of shark squalene
Go to article:
Without a trace: can pharma reduce scarring?
Go to article:
Blood plasma production: OK for the UK?
Go to article:
When the drugs don’t work: can pharma keep up with mental health?
Go to article:
The Solubility Company - Company Insight
Go to article:
The Solubility company
Go to article:
Owen Mumford Company Insight
Go to article:
Owen Mumford
Go to article:
In Data
Go to article:
Deals analysis
Go to article:
The pharma industry key list
Go to article:
Global markets and indices
Go to article:
Macro-economic indicators
Go to article:
Macro-economic indicators (page 2)
Go to article:
Events
Go to article:
Next issue